6 March 2017 - Introduction of a patient alert card for medicinal products containing valproate
In view of renewed discussions and assessments on a European level as well as current findings and discussions with scientific societies, the BfArM considers the introduction of a patient alert card as a further risk minimisation measure to be necessary.

To the risk assessment procedure (available in German only)

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

Valproate and related substances